Evidence map›Paper›PMID 34536052›Full record

ArticleAmerican journal of medical genetics. Part A2022

Impact of the coronavirus pandemic on mental health and health care in adults with neurofibromatosis: Patient perspectives from an online survey.

Pamela L Wolters, Stephanie Reda, Staci Martin, Nour Al Ghriwati, Melissa Baker, Dale Berg, Gregg Erickson, Barbara Franklin, Vanessa L Merker, Beverly Oberlander and 5 more

Open access · greenAbstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.Genetics in medicine : official journal of the American College of Medical Genetics · 2023
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Pamela L WoltersPediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0001-9319-6281
Stephanie RedaPediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Staci MartinPediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Nour Al GhriwatiPediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Melissa BakerPediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Dale BergResponse Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration.
Gregg EricksonResponse Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration.
Barbara FranklinResponse Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration.
Vanessa L MerkerDepartment of Neurology and Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Beverly OberlanderResponse Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration.
Stephanie ReeveResponse Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration.
Claas RohlResponse Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration.
Tena RosserDivision of Neurology, Children's Hospital Los Angeles, Los Angeles, California, USA.
Mary Anne Toledo-TamulaClinical Research Directorate (CRD), Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Ana-Maria VranceanuDepartment of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0003-3994-6488
National Institutes of Health · USChildren's Hospital of Los Angeles · USFrederick National Laboratory for Cancer Research · USHarvard University · USMassachusetts General Hospital · US

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI PENDLETON, RICHARD · 2019 to 2025
$3932.6M
Intramural NIH HHS Z99 CA999999Intramural Research Program of the National Institutes of HealthNational Cancer Intstitute, National Institutes of Health 75N91019F00129NCI NIH HHS 75N91019D00024
6 · The paper itself

Abstract

The coronavirus pandemic increased anxiety and stress and prevented access to health care worldwide; it is unclear how COVID-19 affected adults with a multisystem genetic disorder such as neurofibromatosis (NF). An anonymous online survey was distributed through an international registry and foundations to adults with NF (June-August 2020) to assess the impact of the pandemic on mental health and NF health care. Six hundred and thirteen adults (18-81 years; M = 45.7) with NF1 (77.8%), NF2 (14.2%), and schwannomatosis (7.8%) provided complete responses. Respondents rated moderate-to-high amounts of worry about the impact of COVID-19 on their emotional (46.3%) and physical health (46.7%), and 54.8% endorsed moderate-to-high pandemic-related stress. Adults with diagnosed/suspected mental health disorders or moderate-to-severe NF symptom impact as well as females endorsed higher COVID-19 stress (ps < 0.01). Less than half who missed a doctor's appointment for their NF care (43.4%) used telehealth. Of these, 33.3% and 46.2% reported that telehealth met their needs to a moderate or high degree, respectively. Results indicated that subgroups of adults with NF experience higher COVID-19-related worries and stress and may need additional support. Furthermore, telehealth is under-utilized and could help NF providers connect with patients, although improved delivery and patient training may facilitate expanded use of these services.

Indexed as

AdolescentAdultAgedAged, 80 and overAnxietyCOVID-19EuropeFemaleHumansMaleMental HealthMiddle AgedNeurofibromatosesSARS-CoV-2Stress, PsychologicalSurveys and QuestionnairescoronavirusCOVID-19neurofibromatosispsychosocialtelehealth

Identifiers

PMID34536052
PMCPMC8652613
OpenAlexW3199858327

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.